Overlap phenotype in severe asthma
| Author (year) | n (%) | % male | FEV1, predicted, post bronchodilator | Duration | Age of onset | OCS maintenance, % | Airway inflammatory phenotype |
|---|---|---|---|---|---|---|---|
| Moore (2010)24 | 116 (15.9) | 37 | 58 | – | – | 47 | E|N |
| Jang (2013)28 | 21 (21.9) | 38 | 49 | 24 | 24 | – | N |
| Ghebre et al, (2015)21 | 47 (27.4) | 55 | 60 | 9 | – | 40 | N |
| Newby (2014)23 | 54 (15.4) | 43 | 53 | – | 25 | 57 | – |
| Bourdin (2014) (A)26 | 21 (18.8) | 57 | 50 | 34 | – | 62 | – |
| Bourdin (2014) (B)26 | 30 (26.8) | 57 | 52 | 32 | – | 57 | – |
| Moore (2014)29 | 47 (11.1) | 57 | 61 | 28 | 22 | 26 | N |
| Ortega (2014)27 | 102 (16.6) | 20.5 | 66 | 19 | – | 33 | E |
E, eosinophilic; N, neutrophilic; OCS, oral corticosteroid.